We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $73.4B Turnover 30.34%
1-Year Est. Return 32.8%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+7.5%
1 Year Est. Return
+32.8%
3 Year Est. Return
+177.41%
5 Year Est. Return
+184.82%
10 Year Est. Return
+833.33%
AUM
$75.4B
AUM Growth
+$2.26B
Cap. Flow
-$978M
Cap. Flow %
-1.3%
Top 10 Hldgs %
10.8%
Holding
4,600
New
522
Increased
1,665
Reduced
1,688
Closed
669
Avg Time Held
2.7 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$734M
2
BA icon
Boeing
BA
+$493M
3
PFE icon
Pfizer
PFE
+$478M
4
UNH icon
UnitedHealth
UNH
+$440M
5
HON icon
Honeywell
HON
+$364M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.05B
2
AMD icon
Advanced Micro Devices
AMD
+$447M
3
TSM icon
TSMC
TSM
+$441M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$372M
5
XOM icon
ExxonMobil
XOM
+$321M

Sector Composition

Rank Sector Weight
1 Healthcare 20.37%
2 Technology 16.89%
3 Consumer Discretionary 12.71%
4 Industrials 10.16%
5 Consumer Staples 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NVO icon
1
Novo Nordisk
NVO
$174B
$1.72B 2.28%
21,604,576
-3,604,000
-14% -$256M
2013 Q2
39 quarters
AMZN icon
2
Amazon
AMZN
$2.9T
$930M 1.23%
9,000,941
-2,346,059
-21% -$227M
2022 Q3
2 quarters
GILD icon
3
Gilead Sciences
GILD
$210B
$878M 1.17%
10,584,216
+1,381,648
+15% +$114M
2014 Q4
33 quarters
TSLA icon
4
Tesla
TSLA
$1.52T
$835M 1.11%
4,025,051
+620,034
+18% +$108M
2018 Q4
17 quarters
ABNB icon
5
Airbnb
ABNB
$106B
$753M 1%
6,054,556
-2,548,190
-30% -$291M
2021 Q2
7 quarters
UNH icon
6
UnitedHealth
UNH
$314B
$686M 0.91%
1,450,933
+912,256
+169% +$440M
2022 Q4
1 quarter
VRSN icon
7
VeriSign
VRSN
$27.5B
$673M 0.89%
3,183,090
+97,700
+3% +$20.1M
2013 Q2
39 quarters
HSY icon
8
Hershey
HSY
$35.4B
$586M 0.78%
2,303,367
-361,800
-14% -$85M
2013 Q2
39 quarters
BA icon
9
Boeing
BA
$129B
$551M 0.73%
2,592,100
+2,370,800
+1,071% +$493M
2022 Q4
1 quarter
CVX icon
10
Chevron
CVX
$402B
$526M 0.7%
3,224,589
+1,973,135
+158% +$331M
2020 Q2
11 quarters
FNV icon
11
Franco-Nevada
FNV
$45.8B
$506M 0.67%
3,473,503
-149,300
-4% -$20.8M
2014 Q1
36 quarters
UTHR icon
12
United Therapeutics
UTHR
$24.6B
$499M 0.66%
2,227,414
-117,078
-5% -$28.9M
2013 Q2
39 quarters
PFE icon
13
Pfizer
PFE
$160B
$496M 0.66%
12,149,955
+11,078,514
+1,034% +$478M
2022 Q3
2 quarters
KR icon
14
Kroger
KR
$40.8B
$495M 0.66%
10,028,854
-1,011,400
-9% -$46.2M
2019 Q2
15 quarters
ZM icon
15
Zoom
ZM
$27B
$485M 0.64%
6,573,415
-446,300
-6% -$32.2M
2020 Q1
12 quarters
ABT icon
16
Abbott
ABT
$181B
$456M 0.61%
4,507,066
+1,742,500
+63% +$184M
2021 Q3
6 quarters
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$136B
$440M 0.58%
1,397,735
-849,017
-38% -$255M
2017 Q1
24 quarters
FTNT icon
18
Fortinet
FTNT
$96.8B
$414M 0.55%
6,230,645
+1,958,200
+46% +$111M
2015 Q3
30 quarters
INCY icon
19
Incyte
INCY
$24B
$405M 0.54%
5,602,433
+1,034,200
+23% +$80.9M
2017 Q4
21 quarters
META icon
20
Meta Platforms (Facebook)
META
$1.58T
$405M 0.54%
1,908,583
-78,697
-4% -$13.4M
2021 Q3
6 quarters
RBLX icon
21
Roblox
RBLX
$33.9B
$395M 0.52%
8,781,082
-1,369,900
-13% -$52.4M
2021 Q2
7 quarters
CRWD icon
22
CrowdStrike
CRWD
$243B
$383M 0.51%
11,161,600
+5,219,836
+88% +$151M
2020 Q1
12 quarters
CVS icon
23
CVS Health
CVS
$104B
$377M 0.5%
5,069,953
+2,508,500
+98% +$210M
2021 Q1
8 quarters
SNOW icon
24
Snowflake
SNOW
$98.6B
$374M 0.5%
2,422,599
+570,700
+31% +$83.7M
2022 Q1
4 quarters
HZNP
25
DELISTED
Horizon Therapeutics
HZNP
$368M 0.49%
3,368,449
+1,693,400
+101% +$187M
2017 Q2
23 quarters

Similar funds

Jim Simons's Q1 2023 Portfolio in Review

As of Q1 2023, Jim Simons held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons's Q1 2023 filing shows 522 new, 1,665 increased, 1,688 reduced and 669 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jim Simons's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
  • Jim Simons added most to First Republic Bank in Q1 2023, an estimated $734M increase.
  • Jim Simons's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
  • Jim Simons fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
  • Jim Simons's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
  • Jim Simons opened 522 new positions and closed 669 in Q1 2023.
  • Jim Simons's portfolio value rose 3.1% quarter-over-quarter to $75.4B.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.